Researchers from Baxter International Inc. recently published a study in PLOS ONE that shows remote monitoring technology (telemedicine) for health conditions can be beneficial to patients. Read More »
ACADIA Pharmaceuticals, a biopharmaceutical company that is dedicated to creating and selling novel medicines to resolve the unmet medical needs of central nervous system disorders, recently joined the Russell 1000 Index. Read More »
Sanofi and Boehringer Ingelheim (BI) recently formed a definitive agreement to swap the animal health branch of Sanofi and the consumer health care branch of Boehringer Ingelheim. Read More »
Baxter International recently announced that its AMIA Automated Peritoneal Dialysis (APD) System, which uses the SHARESOURCE Connectivity Platform, has gained approval from Health Canada. Read More »
Digital coupons available through product detail pages, search results and on the mobile app. Read More »
Naloxone now available in CVS Pharmacies in New Mexico; state and county officials applaud efforts to reduce overdose deaths. Read More »
Array BioPharma recently announced that it has sent the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for its binimetinib treatment for patients who have advanced NRAS-mutant melanoma. Read More »
Crown Bioscience (CrownBio), Crown Bioscience International’s wholly owned subsidiary and a worldwide development services company, recently launched its own six new recombinant cell lines dedicated to drug screening, biological studies, development, and discovery. Read More »
Aratana Therapeutics, Inc., a pet therapeutics company that is dedicated to developing, licensing, and selling innovative biopharmaceutical products specifically for companion animals, recently sent an administration New Animal Drug Application (NADA) to the U.S. Food and Drug Administration (FDA) for its new NOCITA. Read More »
Companies working together in a Phase III study of an oral treatment for shingles outbreaks. Read More »
Approval includes intravenous use in hospitalized patients with gram-negative bacterial infections. Read More »
Calls on Congress to ban direct-to-consumer advertising; approves policies to help prevent controlled substance abuse. Read More »
Company to focus on core assets Mino-Lok and Hydro-Lido. Read More »
Twenty-year FDA veteran tapped to lead OCE through initial phase. Read More »
Two software programs to integrate and automate medical reviews and payment authorizations. Read More »
Patent submitted to the FDA Orange Book for approval on June 28. Read More »
The agreements allow AstraZeneca to focus on its main therapy areas. Read More »
Ampio Pharmaceuticals Inc. recently announced the results from its PIVOT clinical trials to access the efficacy and safety of Ampion intra-articular injection among patients who have pain from osteoarthritis (OA) in their knees. Read More »
Store scheduled to open in the mixed use complex in December. Read More »
Copay increases could affect TRICARE beneficiaries' access to prescriptions. Read More »
Alerts Sign-up
